Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,974,277 papers from all fields of science
Search
Sign In
Create Free Account
Alpha Fetoprotein L1 Measurement
Known as:
AFPL1
, Alpha Fetoprotein L1
The determination of the amount of alpha fetoprotein L1 present in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
N. Fraleigh
,
R. Oliva
,
+4 authors
Hoang-Thanh Le
PLoS ONE
2019
Corpus ID: 201630825
Despite the increased risks of cancers and cardiovascular related diseases, tobacco smoking continues to be prevalent in the…
Expand
2016
2016
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
N. Fraleigh
,
Justin Boudreau
,
+7 authors
Hoang-Thanh Le
Heliyon
2016
Corpus ID: 16345883
2014
2014
Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.
B. Romeu
,
M. Lastre
,
+6 authors
O. Pérez
Vaccine
2014
Corpus ID: 34892427
Review
2013
Review
2013
Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform
O. Pérez
,
B. Romeu
,
+9 authors
M. Lastre
Frontiers in Immunology
2013
Corpus ID: 1411280
The development of effective vaccines against neglected diseases, especially those associated with poverty and social deprivation…
Expand
Highly Cited
2010
Highly Cited
2010
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
J. D. del Campo
,
M. Lindqvist
,
+5 authors
A. Harandi
Vaccine
2010
Corpus ID: 22203258
2009
2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
J. D. Campo
,
C. Zayas
,
+7 authors
M. Lastre
Methods
2009
Corpus ID: 22450178
Review
2009
Review
2009
Adjuvant strategies required for targeting mucosal tissues.
V. Ferro
,
O. Pérez
Methods
2009
Corpus ID: 7731238
2009
2009
Mucosal immune response induced by proteoliposome and cochleate derived from serogroups B N. meningitidis
J. D. Campo
,
M. Lastre
,
+8 authors
O. Pérez
2009
Corpus ID: 56217000
Mucosal vaccination offers attractive advantages to conventional systemic vaccination. Most pathogens enter or establish…
Expand
Highly Cited
2007
Highly Cited
2007
New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1
O. Pérez
,
M. Lastre
,
+16 authors
C. Campa
Scandinavian Journal of Immunology
2007
Corpus ID: 27122253
Neisseria meningitidis B proteoliposome (AFPL1 when used as adjuvant) and its derivative‐Cochleate (AFCo1) contain…
Expand
2006
2006
NATURAL Neissera DERIVE PROTEOLIPOSOME AND COCHLEATE AS POTENT VACCINE ADJUVANTS
O. Pérez
,
M. Lastre
,
+11 authors
G. Sierra
2006
Corpus ID: 86101066
Summary Proteoliposome (AFPL1) and its derivated - Cochleate (AFCo1) contain immunopotentiating and immunomodulatory properties…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE